Biotron

(OTC) BITRF

Current Price$0.00

Market Cap$5.40M

Since IPO (2013)-99%

5 Year-94%

1 Year-79%

1 Month-60%

Biotron Financials at a Glance

Market Cap

$5.40M

Revenue (TTM)

A$1.81M

Net Income (TTM)

-A$3.35M

EPS (TTM)

-$0.00

P/E Ratio

-1.82

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$0.00

Volume

300,000

Open

$0.00

Price

$0.00

Volume

300,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

Feb 26, 2026

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$0.00

Volume

300,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

Feb 26, 2026

BITRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biotron

Industry

Biotechnology

Sector

Health Care

CEO

Michelle Miller, PhD

Website

www.biotron.com.au

Headquarters

Sydney, NSW 2000, AU

BITRF Financials

Key Financial Metrics (TTM)

Gross Margin

190.21%

Operating Margin

222203.69%

Net Income Margin

223061.06%

Return on Equity

-119.12%

Return on Capital

-61.38%

Return on Assets

-50.16%

Earnings Yield

-54.95%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.40M

Shares Outstanding

2.70B

Volume

300.00K

Avg. Volume

14.56K

Financials (TTM)

Gross Profit

A$1.78M

Operating Income

-A$3.37M

EBITDA

-A$3.35M

Operating Cash Flow

-A$1.74M

Capital Expenditure

-A$3.07K

Free Cash Flow

-A$1.74M

Cash & ST Invst.

A$1.64M

Total Debt

A$0.00

Biotron Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$782.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$5.40M

N/A

Market Cap/Employee

$1.80M

N/A

Employees

N/A

Net Income

-A$920.61K

+30.5%

EBITDA

-A$891.81K

+34.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$1.64M

+127.5%

Total Debt

A$0.00

-100.0%

Accounts Receivable

A$0.00

N/A

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

-100.0%

Return on Assets

-50.16%

N/A

Return on Invested Capital

-71.46%

N/A

Free Cash Flow

-A$868.08K

+73.4%

Operating Cash Flow

-A$868.08K

+73.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GRCUGlobal Roundtable Corporation

GRCUGlobal Roundtable Corporation$0.00+0.00%

TSOITherapeutic Solutions International, Inc.

TSOITherapeutic Solutions International, Inc.$0.00+0.00%

DYNTDynatronics Corporation

DYNTDynatronics Corporation$0.04+0.00%

VIRXViracta Therapeutics, Inc.

VIRXViracta Therapeutics, Inc.$0.01+0.00%

BPTSYBiophytis S.A.

BPTSYBiophytis S.A.$0.25+0.00%

PFNDPathfinder Cell Therapy, Inc.

PFNDPathfinder Cell Therapy, Inc.$0.00+0.00%

MCETMultiCell Technologies, Inc.

MCETMultiCell Technologies, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

NOKNokia

NOKNokia$12.07-0.07%

Questions About BITRF

What is the current price of Biotron?

Biotron is trading at $0.00 per share.

What is the 52-week range for Biotron?

Over the past 52 weeks, Biotron has traded between $0.00 and $0.10.

How much debt does Biotron have?

As of the most recent reporting period, Biotron reported total debt of A$0.00.

How much cash does Biotron have on hand?

Biotron reported A$610.57K in cash and cash equivalents in its most recent financial results.

What is Biotron’s dividend yield?

Biotron does not currently have a dividend yield.

Biotron

Biotron Financials at a Glance

BITRF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Biotron

BITRF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Biotron Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BITRF

What is the current price of Biotron?

What is the 52-week range for Biotron?

How much debt does Biotron have?

How much cash does Biotron have on hand?

What is Biotron’s dividend yield?

Premium Investing Services